Ionsys Related Published Studies
Well-designed clinical trials related to Ionsys (Fentanyl Transdermal)
Six- versus 12-h conversion method from intravenous to transdermal fentanyl in chronic cancer pain: a randomized study. [2011.05]
Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models. [2011.04]
Bioequivalence and safety of a novel fentanyl transdermal matrix system compared with a transdermal reservoir system. [2011.03]
Six- versus 12-h conversion method from intravenous to transdermal fentanyl in
chronic cancer pain: a randomized study. [2011]
The post-operative analgesic effects of epidurally administered morphine and transdermal fentanyl patch after ovariohysterectomy in dogs. [2010.11]
Transdermal fentanyl matrix patches Matrifen and Durogesic DTrans are bioequivalent. [2010.06]
Safety and tolerability of fentanyl iontophoretic transdermal system: findings from a pooled data analysis of four clinical trials. [2010.05]
The effect of transdermal nitroglycerine on intrathecal fentanyl with bupivacaine for postoperative analgesia following gynaecological surgery. [2010.03]
Low doses of transdermal fentanyl in opioid-naive patients with cancer pain. [2010]
Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. [2009.08]
Comparison of the analgesic properties of transdermally administered fentanyl and intramuscularly administered buprenorphine during and following experimental orthopedic surgery in sheep. [2009.03]
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. [2008.11]
[Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer] [2008.07]
Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine. [2007.12.21]
Improved cancer pain treatment using combined fentanyl-TTS and tramadol. [2007.12]
Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery. [2007.11]
Iontophoretic transdermal system using fentanyl compared with patient-controlled intravenous analgesia using morphine for postoperative pain management. [2007.06]
Effect of local administration of transdermal fentanyl on peripheral opioid analgesia. [2007.01]
Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine. [2006.12.15]
Fentanyl iontophoretic transdermal system for acute-pain management after orthopedic surgery: A comparative study with morphine intravenous patient-controlled analgesia. [2006.11]
Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial. [2006.06]
Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects. [2006.06]
Effect of transdermally administered fentanyl on minimum alveolar concentration of isoflurane in normothermic and hypothermic dogs. [2006.04.01]
A comparison of the skin irritation potential of transdermal fentanyl versus transdermal buprenorphine in middle-aged to elderly healthy volunteers. [2006.03]
[No potentiation of fentanyl by use of transdermal buprenorphine in patients undergoing fast-track anesthesia for open-heart surgery] [2006.02]
An iontophoretic fentanyl patient-activated analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial. [2006.01]
Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain. [2005.11.15]
Comparison of transdermal fentanyl with codeine/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain. [2005.09]
Relationship between plasma concentrations and analgesia after intravenous fentanyl and disposition after other routes of administration in cats. [2005.02]
Effects of application site and subject demographics on the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS). [2005]
The effect of dosing frequency on the pharmacokinetics of a fentanyl HCl patient-controlled transdermal system (PCTS). [2005]
Urine concentrations of fentanyl and norfentanyl during application of Duragesic transdermal patches. [2004.09]
Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain. [2004.07]
Effect of transdermally administered fentanyl on the minimum alveolar concentration of isoflurane in cats. [2004.07]
The effect of inhalant anesthetic and body temperature on peri-anesthetic serum concentrations of transdermally administered fentanyl in dogs. [2004.04]
Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. [2004.03.17]
Plasma fentanyl concentrations and analgesic effects during full or partial exposure to transdermal fentanyl patches in cats. [2004.03.01]
The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia: a multicenter, placebo-controlled trial. [2004.02]
Radiotherapy plus either transdermal fentanyl or paracetamol and codeine for painful bone metastases: a randomised study of pain relief and quality of life. [2004]
Plasma fentanyl concentrations in awake cats and cats undergoing anesthesia and ovariohysterectomy using transdermal administration. [2003.10]
The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat. [2003.08]
Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. [2003]
Transdermal fentanyl for the management of acute pancreatitis pain. [2002.05]
Comparison of transdermal administration of fentanyl versus intramuscular administration of butorphanol for analgesia after onychectomy in cats. [2002.04.01]
Analgesic effect of the transdermal fentanyl patch during and after feline ovariohysterectomy. [2001.07]
Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. [2001.05.12]
From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial. [2001.05]
Long-term observations of patients receiving transdermal fentanyl after a randomized trial. [2001.05]
Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). [2001.03]
Evaluation of transdermal fentanyl patches for analgesia in cats undergoing onychectomy. [2000.10.01]
Assessing the impact of heat on the systemic delivery of fentanyl through the transdermal fentanyl delivery system. [2000.09]
Reproducible fentanyl doses delivered intermittently at different time intervals from an electrotransport system. [1999.08]
A comparison of transdermal fentanyl versus epidural morphine for analgesia in dogs undergoing major orthopedic surgery. [1999.03]
Prolonged treatment with transdermal fentanyl in neuropathic pain. [1998.10]
Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. [1998.10]
Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. [1998.04.15]
Transdermal fentanyl for pain control in adults with chronic cancer pain. [1998.03]
Comparison of plasma fentanyl concentrations by using three transdermal fentanyl patch sizes in dogs. [1998.03]
Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. [1997.05]
Transdermal fentanyl system plus im ketorolac for the treatment of postoperative pain. [1997.04]
Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. [1997.03]
Transdermal fentanyl in postoperative pain. [1997.01]
Disposition of transdermally administered fentanyl in dogs. [1996.05]
Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients. [1996.03]
Postoperative pain control with a new transdermal fentanyl delivery system. A multicenter trial. [1995.09]
Respiratory changes during treatment of postoperative pain with high dose transdermal fentanyl. [1995.08]
The iontophoresis of fentanyl citrate in humans. [1995.05]
Postoperative analgesia with transdermal fentanyl following lower abdominal surgery. [1995.04]
Postoperative analgesia and plasma levels after transdermal fentanyl for orthopedic surgery: double-blind comparison with placebo. [1995.02]
A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects. [1994.11]
Impaired memory and behavioral performance with fentanyl at low plasma concentrations. [1994.11]
Transdermal fentanyl improves management of postoperative hemorrhoidectomy pain. [1994.11]
Continuous administration of fentanyl for postoperative pain: a comparison of the epidural, intravenous, and transdermal routes. [1994.07]
Postoperative pain control by transdermal fentanyl. Preliminary comparison of two dosages to a fixed-interval i.m. morphine regimen. [1992.12]
Transdermal fentanyl for postoperative pain management in patients recovering from abdominal gynecologic surgery. [1992.09]
Transdermal fentanyl for the treatment of pain after major urological operations. A randomized double-blind comparison with placebo using intravenous patient-controlled analgesia. [1991]
Transdermal fentanyl for the relief of pain after upper abdominal surgery. [1989.07]
Transdermal fentanyl for postoperative pain management. A double-blind placebo study. [1989.02.17]
Transdermal fentanyl against postoperative pain. [1989]
Postoperative analgesia with fentanyl: pharmacokinetics and pharmacodynamics of constant-rate i.v. and transdermal delivery. [1988.05]
Well-designed clinical trials possibly related to Ionsys (Fentanyl Transdermal)
Transdermal opioids for cancer pain. [2011.03]
Efficacy of oxycodone/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial. [2011.01.05]
Physical therapists' perceptions of ease of care in patients receiving 2 forms of analgesia after total hip arthroplasty. [2010.05]
In-office thermachoice III ablation: a comparison of two anesthetic techniques. [2010]
Transdermal nicotine patch failed to improve postoperative pain management. [2008.09]
Transdermal nicotine for analgesia after radical retropubic prostatectomy. [2008.09]
Nurses' views on ease of patient care in postoperative pain management. [2007.03.08]
Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. [2006.04]
Effect of postoperative analgesic protocol on limb function following onychectomy in cats. [2005.07.01]
Intra-articular lidocaine plus bupivacaine in sheep undergoing stifle arthrotomy. [2004.01]
Transdermal nicotine increases heart rate after endotracheal intubation. [2003.06]
Suprascapular nerve block or a piroxicam patch for shoulder tip pain after day case laparoscopic surgery. [2003.03]
Transdermal clonidine: does it affect pain after abdominal hysterectomy? [2003]
Opioid treatment of painful chronic pancreatitis. [2000.06]
Transdermal nitroglycerine enhances spinal sufentanil postoperative analgesia following orthopedic surgery. [1999.03]
Does abstinence from smoking or a transdermal nicotine system influence atracurium-induced neuromuscular block? [1998.08]
Postoperative analgesia with parenteral opioids: does continuous delivery utilizing a transdermal opioid preparation affect analgesic efficacy or patient safety? [1997.05]
Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. [1994.12]
Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period. [1991.02]
Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. [1990.06]
[Methohexital/alfentanil-thiopental/alfentanil for total intravenous anesthesia for direct laryngoscopy with 100% O2 jet ventilation] [1988.08]
|
